We are live on ! Find out more
LXRX icon

Lexicon Pharmaceuticals
LXRX

102 hedge funds and large institutions have $1.12B invested in Lexicon Pharmaceuticals in 2013 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 37 increasing their positions, 27 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

37% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 27

10% more capital invested

Capital invested by funds: $1.02B → $1.12B (+$100M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 8

1% less funds holding

Funds holding: 103 → 102 (-1)

Holders
102
Holders Change
-1
Holders Change %
-0.97%
% of All Funds
3.31%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
8
Increased
37
Reduced
27
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
UBS AM
UBS AM
Illinois
+$11.9M
2
TRSOTSOK
Teachers Retirement System of the State of Kentucky
Kentucky
+$4.86M
3
BFA
BlackRock Fund Advisors
California
+$3.45M
4
Norges Bank
Norges Bank
Norway
+$990K
5
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale
Germany
+$686K

Top Sellers

1
Vanguard Group
Vanguard Group
Pennsylvania
-$4.62M
2
Allianz Asset Management
Allianz Asset Management
Germany
-$3.64M
3
Morgan Stanley
Morgan Stanley
New York
-$2.88M
4
Franklin Resources
Franklin Resources
California
-$1.57M
5
JP Morgan Chase
JP Morgan Chase
New York
-$1.47M
Name Holding Trade Value Shares
Change 		Change in
Stake
California Public Employees Retirement System
26
California Public Employees Retirement System
California
$1.13M +$188K +11,214 +20%
AllianceBernstein
27
AllianceBernstein
Tennessee
$1.07M +$3.44K +205 +0.3%
Axa
28
Axa
France
$1M +$205K +12,220 +25%
California State Teachers Retirement System (CalSTRS)
29
California State Teachers Retirement System (CalSTRS)
California
$969K +$30.8K +1,839 +3%
Bank of America
30
Bank of America
North Carolina
$821K +$56.2K +3,351 +7%
Morgan Stanley
31
Morgan Stanley
New York
$776K -$2.88M -171,744 -79%
ProShare Advisors
32
ProShare Advisors
Maryland
$768K +$214K +12,750 +38%
CS
33
Credit Suisse
Switzerland
$741K +$111K +6,644 +18%
TA
34
Teachers Advisors
New York
$737K +$25.2K +1,504 +4%
DekaBank Deutsche Girozentrale
35
DekaBank Deutsche Girozentrale
Germany
$682K +$686K +40,914 New
PI
36
Putnam Investments
Massachusetts
$658K -$58.4K -3,483 -8%
Goldman Sachs
37
Goldman Sachs
New York
$637K +$439K +26,189 +217%
D.E. Shaw & Co
38
D.E. Shaw & Co
New York
$635K +$350K +20,881 +120%
UOTTAIMCU
39
University of Texas/Texas AM Investment Management Co (UTIMCO)
Texas
$595K – – –
TA
40
Teton Advisors
New York
$559K +$12K +714 +2%
TC
41
TFS Capital
Pennsylvania
$545K +$93.1K +5,554 +20%
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
$542K +$7.11K +424 +1%
Swiss National Bank
43
Swiss National Bank
Switzerland
$512K -$33.5K -2,000 -6%
WHI
44
William Harris Investors
Illinois
$486K – – –
MLICM
45
Metropolitan Life Insurance Company (MetLife)
New York
$448K +$177K +10,528 +64%
NFA
46
Nationwide Fund Advisors
Ohio
$428K +$37.9K +2,261 +10%
CNB
47
City National Bank
California
$394K +$396K +23,641 New
State Board of Administration of Florida Retirement System
48
State Board of Administration of Florida Retirement System
Florida
$382K – – –
AIG
49
American International Group
New York
$366K +$16.2K +963 +5%
GI
50
GAMCO Investors
Connecticut
$341K – – –
1
2
3 4 5

LXRX Hedge Fund Activity: Q3 2013 in Review

102 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Lexicon Pharmaceuticals (LXRX) for Q3 2013, worth a combined $1.12B — up 9.9% from $1.02B a quarter earlier.

Fund positioning in LXRX was balanced in Q3 2013: 8 funds opened new positions, 8 closed out, 37 added to existing stakes and 27 trimmed.

The largest buyer was UBS AM, adding an estimated $11.9M. The largest seller was Vanguard Group, cutting an estimated $4.62M.

  • 102 institutional investors held Lexicon Pharmaceuticals (LXRX) as of Q3 2013, down from 103 in Q2 2013.
  • Funds reported $1.12B of Lexicon Pharmaceuticals stock for Q3 2013, up 9.9% quarter-over-quarter.
  • 8 funds opened new Lexicon Pharmaceuticals positions in Q3 2013 and 8 closed out, a net change of 0 holders.
  • The largest Lexicon Pharmaceuticals buyer in Q3 2013 was UBS AM, an estimated $11.9M added.
  • The largest Lexicon Pharmaceuticals seller in Q3 2013 was Vanguard Group, an estimated $4.62M sold.

Based on aggregated 13F filings for Q3 2013.